Antral Follicle Count, Anti-mullerian Hormone and Inhibin B: Predictors of Ovarian Response in Assisted Reproductive Technology?
Overview
Affiliations
Objective: The objective of this study was to evaluate the relationship between anti-mullerian hormone (AMH), inhibin B and antral follicle count (AFC) with ovarian response.
Design: Retrospective study.
Setting: Fertility unit.
Sample: AFC was recorded, and a serum sample obtained on day 3 from all patients undergoing in vitro fertilisation (IVF). Patients were given 300 IU/L recombinant follicle stimulating hormone (FSH; Gonal F). The following day blood samples were collected. METHODS Serum samples were assayed for FSH, AMH and inhibin B using commercial immunoassay kits and oestradiol using an in house assay.
Main Outcome Measures: Response to gonadotrophin stimulation and the number of eggs collected.
Results: AFC was negatively correlated to age (r=-0.426, P < 0.001). Delta inhibin B (levels of inhibin B on day 4 minus day 3) had the best association to the number of eggs collected (r= 0.533, P < 0.001) followed by basal AMH (r= 0.51, P < 0.001) and AFC (r= 0.505, P < 0.001). The number of eggs fertilised was significantly associated with basal AMH (r= 0.592, P < 0.001) and inhibin B (r= 0.548, P < 0.001). AMH with a cutoff of 0.2 ng/mL had the best sensitivity (87%) and specificity (64%) in predicting poor response. A cumulative score using basal FSH, basal AMH, delta E2 (levels of oestradiol on day 4 minus day 3), delta inhibin B, AFC and age gives the best predictive statistics to identify poor responders with 87% sensitivity and 80% specificity and a positive likelihood ratio of 4.36.
Conclusion: Delta inhibin B had the best positive association with the number of eggs collected and basal AMH is the single best predictor of poor response. AFC has a significant association with the number of eggs collected and is predictive of clinical pregnancy. It is evident that a single parameter is of limited value in predicting ovarian response. However, we have demonstrated a cumulative score using all the above markers could be useful in predicting poor response.
Salemi F, Jambarsang S, Kheirkhah A, Salehi-Abargouei A, Ahmadnia Z, Hosseini H Syst Rev. 2024; 13(1):303.
PMID: 39695880 PMC: 11657140. DOI: 10.1186/s13643-024-02684-0.
Wedrychowicz A, Wojtys J, Janus D, Furtak A, Stelmach M, Starzyk J Heliyon. 2024; 10(22):e40156.
PMID: 39634384 PMC: 11615472. DOI: 10.1016/j.heliyon.2024.e40156.
Sukur Y, Aslan B, Kaplan N, Dogru M, Ozmen B, Sonmezer M J Ovarian Res. 2024; 17(1):209.
PMID: 39456057 PMC: 11515343. DOI: 10.1186/s13048-024-01517-x.
Sen O, Aslan E, Kalayci D, Kucuk A, Baskan S, Sezen S Medicina (Kaunas). 2024; 60(9).
PMID: 39336444 PMC: 11434566. DOI: 10.3390/medicina60091403.
Ovarian response to controlled stimulation and its predictors in a limited-resource setting.
Dermolo M, Ansa M, Siferih M BMC Womens Health. 2024; 24(1):279.
PMID: 38714986 PMC: 11075256. DOI: 10.1186/s12905-024-02991-7.